Status:
COMPLETED
Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.
Lead Sponsor:
Assiut University
Conditions:
No-Reflow Phenomenon
Eligibility:
All Genders
16+ years
Brief Summary
Predicting no reflow in ppci of STEMI patients using mean platelet volume together with STEMI clinical risk scores
Eligibility Criteria
Inclusion
- patients presenting with acute STEMI, within 24 hours of symptoms, fulfilling criteria for PPCI protocol in our facility
Exclusion
- patients presenting more than 24 hours of symptoms onset
- patients not eligible for PPCI program in our facility
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
640 Patients enrolled
Trial Details
Trial ID
NCT04785209
Start Date
September 1 2020
End Date
May 1 2024
Last Update
May 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university hospital
Asyut, Egypt, 71515